Atossa Therapeutics
ATOS
#10646
Rank
NZ$42.44 M
Marketcap
NZ$4.25
Share price
-1.93%
Change (1 day)
228.29%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2026 (TTM): NZ-$6.79

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$6.63. In 2025 the company made an earnings per share (EPS) of NZ-$6.77 a decrease over its 2024 EPS that were of NZ-$5.09.

EPS history for Atossa Therapeutics from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$6.790.3%
2025NZ-$6.7732.89%
2024NZ-$5.09-15.56%
2023NZ-$6.0314.29%
2022NZ-$5.2816.67%
2021NZ-$4.52-90.86%
2020NZ-$49.49-2.96%
2019NZ-$50.99-63.09%
2018NZ-$138.16-49.63%
2017NZ-$274.32-57.87%
2016NZ-$651.13-74.01%
2015NZ-$2,505-9.18%
2014NZ-$2,758-12.86%
2013NZ-$3,16570.73%
2012NZ-$1,85434.07%
2011NZ-$1,383263.41%
2010NZ-$380.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.63-320.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$15.36-331.57%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$19.02-386.87%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.29-80.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ-$0.35-94.70%๐Ÿ‡บ๐Ÿ‡ธ USA